本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ARS PHARMACEUTICALS INC

4.25
-0.2500-5.56%
盤後4.410.1600+3.76%19:47 EDT
成交量:277.62萬
成交額:1,196.93萬
市值:4.23億
市盈率:-1.95
高:4.50
開:4.50
低:4.22
收:4.50
52周最高:13.15
52周最低:4.22
股本:9,944.73萬
流通股本:4,803.45萬
量比:1.78
換手率:5.78%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
淨資產收益率:-210.35%
總資產收益率:-48.02%
市淨率:33.78
市盈率(LYR):-2.44

資料載入中...

2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/09

重要事件披露

Form 8-K - Current report
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/09/29

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities